Dr. Lah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Rd
Atlanta, GA 30322Phone+1 404-778-7525- Is this information wrong?
Education & Training
Emory University School of MedicineResidency, Neurology, 1993 - 1996- Emory University School of MedicineInternship, Internal Medicine, 1992 - 1993
Ohio State University College of MedicineClass of 1992
Ohio State UniversityPh.D., Cell Biology and Neuroscience, 1992
Duke UniversityB.S., Zoology, 1984
Certifications & Licensure
GA State Medical License 1996 - 2025
NC State Medical License 2020 - 2022
AL State Medical License 2020 - 2020- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Outstanding Postdoc Mentor Award Emory University, 2012
- Tomorrow’s Leader in Alzheimer’s Disease Award Int’l Conference on AD, Chicago, IL, 2008
- Research Award for Clinical Trainees National Institutes of Health, 1993
- Join now to see all
Clinical Trials
- Effects of Atomoxetine in Mild Cognitive Impairment Start of enrollment: 2012 Mar 01
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Start of enrollment: 2012 Dec 01
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
- Join now to see all
Publications & Presentations
PubMed
- Association between Fine Particulate Matter Exposure and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease among a Cognitively Healthy Population-Based Cohort.Emma Casey, Zhenjiang Li, Donghai Liang, Stefanie Ebelt, Anke Hüls, Allan I Levey, James J Lah, Thomas S Wingo> ;Environmental Health Perspectives. 2024 Apr 1
- Association of PMExposure and Alzheimer Disease Pathology in Brain Bank Donors-Effect Modification byGenotype.Christensen, G., Li, Z., Liang, D., Ebelt, S., Gearing, M., Hüls, A., Levey, A., Lah, J., Wingo, A., Wingo, T.> ;Neurology. 2024 Mar 12
- Joint effects of air pollution and neighborhood socioeconomic status on cognitive decline - Mediation by depression, high cholesterol levels, and high blood pressure.Yiyang Mei, Grace M Christensen, Zhenjiang Li, Lance A Waller, Stefanie Ebelt, Michele Marcus, James J Lah, Aliza P Wingo, Thomas S Wingo, Anke Hüls> ;The Science of the Total Environment. 2024 May 1
- Join now to see all
Journal Articles
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humansBakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM,..., Proc Natl Acad Sci U S A, 3/1/2012
- Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complexLane RF, Raines SM, Steele JW, Ehrlich ME, Lah JA, Small SA, Tanzi RE, Attie AD, Gandy S, J Neurosci, 9/1/2010
Press Mentions
Newly Approved Alzheimer's Disease Drug Gives Hope to WYFF News 4'S Geoff HartJune 10th, 2021- Can Flickering Light and Sound Treat Alzheimer’s?June 8th, 2021
- Cajoling Brain Cells to DanceJune 4th, 2021
- Join now to see all
Grant Support
- Clinical CoreNational Institute On Aging2010–2012
- APOE Receptor LR11 In Alzheimer'S EtiopathogenesisNational Institute On Aging2004–2007
- Structure And Function Of Alzheimers Disease ProteinsNational Institute Of Neurological Disorders And Stroke1996–2000
Hospital Affiliations
Southern Regional Medical CenterRiverdale, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
